Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies.

National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA.
Sex Transm Dis (Impact Factor: 2.75). 02/2006; 33(1):36-51. DOI: 10.1097/01.olq.0000187908.42622.fd
Source: PubMed

ABSTRACT Studies of condom use to reduce risk of most sexually transmitted infection provide inconsistent results. This inconsistency is often attributed to methodologic limitations yet has not been assessed systematically.
The objectives of this study were to review studies of condom use and risk of gonorrhea and chlamydia, and to evaluate the importance of 4 key design and measurement factors on condom effectiveness estimates.
We reviewed studies published 1966-2004 to assess risk reduction for gonorrhea and/or chlamydia associated with male condom use.
Of 45 studies identified, most found reduced risk of infection associated with condom use. All studies reviewed had methodologic limitations: only 28 (62%) distinguished consistent from inconsistent use; 2 (4%) reported on correct use or use problems; 13 (29%) distinguished incident from prevalent infection; and one (2%) included a population with documented exposure to infection. Eight of 10 studies with 2 or more of these attributes reported statistically significant protective effects for condom use versus 15 of 35 studies with zero or one attribute (80% vs. 43%, P = 0.04).
Condom use was associated with reduced risk of gonorrhea and chlamydia in men and women in most studies, despite methodologic limitations that likely underestimate condom effectiveness. Epidemiologic studies that better address these factors are needed to provide more accurate assessment of condom effectiveness.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The Health & Relationships in the New Millennium is an abstinence-only-until-marriage curriculum for seventh and eighth grade students. The curriculum aims to promote sexual abstinence until marriage by teaching about character, values, goals, relationships, communication, peer pressure, media influences, puberty and reproductive anatomy, pregnancy and birth, parenting, and sexually transmitted diseases. This curriculum has many positive aspects, such as encouraging parental involvement, teaching the importance of having goals, teaching about empathy, and developing communications skills. In an attempt to teach students that heterosexual activity should occur only within a marriage, however, the curriculum fails to maintain this positive approach in all of its lessons. Overall, this curriculum does not meet the California Education Code's mandates for the Authorized Comprehensive Sexual Health Education or the Required HIV/AIDS Prevention Education.
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Infections can impact the reproductive health of women and hence may influence pregnancy related outcomes for both the mother and the child. These infections range from sexually transmitted infections (STIs) to TORCHS infections to periodontal disease to systemic infections and may be transmitted to the fetus during pregnancy, labor, delivery or breastfeeding. A systematic review and meta-analysis of the evidence was conducted to ascertain the possible impact of preconception care for adolescents, women and couples of reproductive age on MNCH outcomes. A comprehensive strategy was used to search electronic reference libraries, and both observational and clinical controlled trials were included. Cross-referencing and a separate search strategy for each preconception risk and intervention ensured wider study capture. Preconception behavioral interventions significantly declines re-infection or new STI rates by 35% (95% CI: 20-47%). Further, condom use has been shown to be the most effective way to prevent HIV infection (85% protection in prospective studies) through sexual intercourse. Intervention trials showed that preconception vaccination against tetanus averted a significant number of neonatal deaths (including those specifically due to tetanus) when compared to placebo in women receiving more than 1 dose of the vaccine (OR 0.28; 95% CI: 0.15-0.52); (OR 0.02; 95% CI: 0.00-0.28) respectively. Preconception counseling should be offered to women of reproductive age as soon as they test HIV-positive, and conversely women of reproductive age should be screened with their partners before pregnancy. Risk assessment, screening, and treatment for specific infections should be a component of preconception care because there is convincing evidence that treatment of these infections before pregnancy prevents neonatal infections.
    Reproductive Health 09/2014; 11 Suppl 3:S4. DOI:10.1186/1742-4755-11-S3-S4 · 1.62 Impact Factor

Full-text (2 Sources)

Available from
Jan 26, 2015